Quinn Opportunity Partners LLC Poseida Therapeutics, Inc. Transaction History
Quinn Opportunity Partners LLC
- $1.33 Billion
- Q4 2024
A detailed history of Quinn Opportunity Partners LLC transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 58,227 shares of PSTX stock, worth $553,156. This represents 0.04% of its overall portfolio holdings.
Number of Shares
58,227Holding current value
$553,156% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding PSTX
# of Institutions
119Shares Held
40.7MCall Options Held
135KPut Options Held
439K-
Pentwater Capital Management LP Naples, FL8.63MShares$81.9 Million0.95% of portfolio
-
Nomura Holdings Inc Tokyo, M05.12MShares$48.6 Million0.07% of portfolio
-
Black Rock Inc. New York, NY4.91MShares$46.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.83MShares$36.4 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.02MShares$19.2 Million1.2% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $815M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...